Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial.
暂无分享,去创建一个
L. Holmberg | J. Palmgren | H. Adami | J. Johansson | A. Vickers | G. Steineck | H. Garmo | A. Bill-Axelson | Caroline J Bennette
[1] David S. Yee,et al. Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer. , 2011, The Journal of urology.
[2] Kirsten L. Greene,et al. Outcomes of active surveillance for men with intermediate-risk prostate cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Jack Hadley,et al. Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data. , 2010, Journal of the National Cancer Institute.
[4] Susan T. Stewart,et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. , 2010, JAMA.
[5] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[6] L. Klotz,et al. Active surveillance for prostate cancer: patient selection and management. , 2010, Current oncology.
[7] V. Laudone,et al. Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy. , 2010, The Journal of urology.
[8] D. Dearnaley,et al. A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance. , 2009, European urology.
[9] Michael Seitz,et al. Insignificant prostate cancer and active surveillance: from definition to clinical implications. , 2009, European urology.
[10] Andrew J Vickers,et al. The surgical learning curve for laparoscopic radical prostatectomy: a retrospective cohort study. , 2009, The Lancet. Oncology.
[11] L. Holmberg,et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. , 2008, Journal of the National Cancer Institute.
[12] M. Cooperberg,et al. Active surveillance for the management of prostate cancer in a contemporary cohort , 2008, Cancer.
[13] T. Wilt,et al. Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer , 2008, Annals of Internal Medicine.
[14] E. Metter,et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. , 2007, The Journal of urology.
[15] E. Metter,et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience , 2007 .
[16] M. Kattan,et al. The surgical learning curve for prostate cancer control after radical prostatectomy. , 2007, Journal of the National Cancer Institute.
[17] P. Ravdin,et al. A decision aid to assist in adjuvant therapy choices for breast cancer , 2006, Psycho-oncology.
[18] James A Hanley,et al. Prostate cancer and the Will Rogers phenomenon. , 2005, Journal of the National Cancer Institute.
[19] M. Cooperberg,et al. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). , 2003, The Journal of urology.
[20] Les M Irwig,et al. An evidence based approach to individualising treatment , 1995, BMJ.
[21] Liying Zhang,et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.